Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
Lima ACM, Getz J, do Amaral GB, Loth G, Funke VAM, Nabhan SK, Petterle RR, de Marco R, Gerbase-DeLima M, Pereira NF, Bonfim C, Pasquini R. Lima ACM, et al. Among authors: de marco r. Transplant Cell Ther. 2023 Aug;29(8):493.e1-493.e10. doi: 10.1016/j.jtct.2023.05.014. Epub 2023 May 21. Transplant Cell Ther. 2023. PMID: 37220839
Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donor.
Ferreira AN, Felipe CR, Cristelli M, Viana L, Mansur J, de Paula M, Wagner D, de Marco R, Gerbase-DeLima M, Proença H, Aguiar W, Medina-Pestana J, Tedesco-Silva Junior H. Ferreira AN, et al. Among authors: de marco r, de paula m. Transpl Int. 2019 Nov;32(11):1127-1143. doi: 10.1111/tri.13478. Epub 2019 Aug 27. Transpl Int. 2019. PMID: 31278785 Free article. Clinical Trial.
Long-term Efficacy and Safety of Everolimus Versus Mycophenolate in Kidney Transplant Recipients Receiving Tacrolimus.
Nunes Ficher K, Dreige Y, Gessolo Lins PR, Nicolau Ferreira A, Toniato de Rezende Freschi J, Linhares K, Stopa Martins S, Custodio L, Cristelli M, Viana L, Wagner Santos D, de Marco R, Gerbase-DeLima M, Proença H, Aguiar W, Nakamura M, Rosso Felipe C, Medina Pestana J, Tedesco Silva H Jr. Nunes Ficher K, et al. Among authors: de marco r. Transplantation. 2022 Feb 1;106(2):381-390. doi: 10.1097/TP.0000000000003714. Transplantation. 2022. PMID: 33988338 Clinical Trial.
HLA-A homozygosis is associated with susceptibility to COVID-19.
De Marco R, Faria TC, Mine KL, Cristelli M, Medina-Pestana JO, Tedesco-Silva H, Gerbase-DeLima M. De Marco R, et al. HLA. 2021 Aug;98(2):122-131. doi: 10.1111/tan.14349. Epub 2021 Jun 29. HLA. 2021. PMID: 34165257 Free PMC article.
Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders.
Lima ACM, Bonfim C, Getz J, do Amaral GB, Petterle RR, Loth G, Nabhan SK, de Marco R, Gerbase-DeLima M, Pereira NF, Pasquini R. Lima ACM, et al. Among authors: de marco r. Transplant Cell Ther. 2022 Oct;28(10):698.e1-698.e11. doi: 10.1016/j.jtct.2022.07.019. Epub 2022 Jul 23. Transplant Cell Ther. 2022. PMID: 35882362 Free article.
575 results